Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...

Drugmaker Novo Nordisk received accelerated approval for the drug’s use in people with moderate to advanced liver scarring, ...

Novo Nordisk slashes Wegovy prices by 50% for cash-paying patients amid Trump's pressure on drugmakers to reduce costs.

As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

FAT jabs have turned the tide on the obesity epidemic, but there’s a new challenge on the horizon – an obesity bounceback.

Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.

Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...

We live in a world where $1 billion of prescription medications are left at the pharmacy counter each year, often because ...

Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type ...

The approval makes Wegovy the only GLP-1 therapy cleared to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis. About 14.9 million U.S.

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily ...